Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

Cost-effectiveness of bevacizumab versus ranibizumab for treatment-requiring retinopathy of prematurity: a multicenter real-world cohort study
Дата публикации: 19-08-2026 10:35:09

An article created on 2026-08-19 10:35:09

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Topical ketorolac and nepafenac prophylaxis in early retinopathy of prematurity: real-world clinical evidence from a multicenter care network in Colombia016.6419-08-2026
2Comparison of early ocular biological parameters in preterm infants with or without Retinopathy of Prematurity013.6120-08-2026
3An Intelligent Multimodal Deep Learning Framework for Early Diagnosis of Diabetic and Hypertensive Retinopathy Using Retinal Fundus Images013.1820-08-2026
4A Case of Bilateral Sequential Central Retinal Vein Occlusion Secondary to Chronic Myeloid Leukemia01519-08-2026
5Endoscopic Versus Open Partial Plantar Fasciectomy for Solitary Plantar Fibromatosis: A Retrospective Cohort Study With Minimum 2-Year Follow-up017.1719-08-2026
6Longitudinal assessment of the retinal phenotype in patients with Fabry disease undergoing continuous enzyme replacement and/or chaperone therapy014.1719-08-2026
7Separating Biological and Choice Effects in Randomized Trials: Completing Causal Inference with β-Identification020.5320-08-2026
8A head-to-head comparison of the experimental version of EQ-TIPS-3L and EQ-TIPS-5L (EV3.0) in Chinese preterm infants and toddlers027.519-08-2026
9Modified Posterior versus Standard Transperitoneal Laparoscopic Pyelolithotomy: A Randomized Controlled Trial015.8820-08-2026
10Disparities in Drug Access between Japan and the United States for Designated Intractable Diseases: A Cross-Sectional Analysis of Approval Status, Prevalence, and Drug Lag014.9319-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 27.21. Источник: www.researchsquare.com.